alternatives to tirzepatide weight loss medications 9 Mounjaro for and Diabetes F.D.A. Approves New Obesity Drug

Each runners body reacts differently, so monitoring side effects and tracking performance changes is key

Those drugs include semaglutide 1 mg (Ozempic, Novo Nordisk), oral semaglutide (Rybelsus, Novo Nordisk), tirzepatide as approved for diabetes (Mounjaro, Eli Lilly) and liraglutide as approved for diabetes (Victoza, Novo Nordisk)

Given the various co-morbidities associated with obesity, including diabetes and cardiovascular disease, intuitively, it would seem that GLP-1 use for weight loss would be cost-effective and possibly reduce overall medical costs despite the increase in prescription drug spending

Sandeep K